Almirall, S.A. (ALM), a global biopharmaceutical company focused on skin health, announced that it is participating in FACILITATE, (FrAmework for ClInicaL trIal participants’ daTA...
Synaptogenix, Inc., an emerging biopharmaceutical company developing regenerative therapeutics for neurodegenerative disorders, commented on the positive Phase 3 trial results for Lecanemab announced last...
Bugworks Research Inc., a clinical stage biopharmaceutical company, and Cytecare Cancer Hospitals announced the launch of a first-of-its-kind collaboration. Bugworks develops best-in-class, novel therapies...
InnoCare Pharma, a leading biopharmaceutical company for the treatment of cancer and autoimmune diseases, announced that BTK inhibitor orelabrutinib has been granted priority review...
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve the lives of people with cancer, announced...
